TherapeuticsMD (TXMD) Tax Provisions (2011 - 2025)
TherapeuticsMD (TXMD) reported Tax Provisions of -$32000.0 for Q1 2025, up 87.69% quarter-over-quarter from -$260000.0 in Q3 2022.
TherapeuticsMD (TXMD) Tax Provisions (2011 - 2025) Analysis & Trends
TherapeuticsMD has reported Tax Provisions for 3 years, with the latest figure at -$32000.0 in Q1 2025.
- For the quarter ending Q1 2025, Tax Provisions changed N/A year-over-year to -$32000.0; the trailing twelve-month figure through Sep 2025 stood at -$292000.0 (changed N/A YoY), and the FY2024 full-year result was -$31000.0, up 27.91% from the prior year.
- Tax Provisions for Q1 2025 stood at -$32000.0, up from -$260000.0 in the prior quarter.
- The five-year high for Tax Provisions was $600000.0 in Q2 2022, with the low at -$260000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -3.57 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 48.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 37.99 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -9.44 Mn |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -32,000.00 |
| Sep 30, 2022 | -260,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Sep 30, 2011 | 4,304.00 |